HC Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
HC Financial Advisors's PFE Position: Q2 2022 in Review
HC Financial Advisors reduced its Pfizer (PFE) stake by 0.18% in Q2 2022, selling an estimated $5.91K and leaving 62,620 shares worth $3.28M. The position accounts for 2.2% of the portfolio, ranked #10.
HC Financial Advisors first reported a position in PFE in Q4 2017 and has held it in 18 quarters since. The position peaked at $3.94M in Q4 2021. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.
- HC Financial Advisors held 62,620 shares of Pfizer worth $3.28M as of Q2 2022.
- HC Financial Advisors sold 116 Pfizer shares in Q2 2022, an estimated $5.91K.
- Pfizer made up 2.2% of HC Financial Advisors's portfolio in Q2 2022, its #10 holding.
- HC Financial Advisors first reported a position in Pfizer in Q4 2017 and has held it in 18 quarters since.
- HC Financial Advisors's Pfizer position peaked at $3.94M in Q4 2021.
- 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.
Based on HC Financial Advisors's 13F filing for Q2 2022, filed 25 Jul 2022.